Pure form Sealed in dry, 2-8°C
In solvent -20°C:3-6个月-80°C:12个月
1 mM
5 mM
10 mM
2.34mL
0.47mL
0.23mL
11.70mL
1.17mL
23.39mL
4.68mL
[1]E O Stapley, et al. Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis. Jan-Feb 1979;1(1):73-89.
[2]R N Brogden, et al. Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs. 1979 Jan;17(1):1-37.
[3]Venkata Raveendra Pothineni, et al. In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease. Drug Des Devel Ther. 2018; 12: 2915–2921.